FatigueSense
Impact stories, feature updates, and what we are learning from building tools for people with chronic fatigue conditions.
The first five thousand
Around five thousand people now use FatigueSense to pace their days with ME/CFS, long COVID, POTS and fibromyalgia. This report sets out what they have told us and what we are seeing in how these conditions behave from day to day, including why mornings are the most expensive part of the day and why a single good morning is a poor guide to recovery.
One month. 1,000 people. Measurable outcomes.
Six weeks after launch, 1,000 people living with ME/CFS, long COVID, fibromyalgia, RA fatigue, and cancer-related fatigue are using FatigueSense. This report documents who found it, what the early outcomes reveal, and what the gap in existing digital health tools looks like from the ground level.